NMD Pharma - Capnova
NMD Pharma
Neuromuscular Drug Development Summit (NMD) - Pharma Journalist
NMD Pharma - Inkef capital
Klaus Wilhardt - Corporate identity, Design, Logo/navnetræk og designguides
NMD Pharma raises $47M in series A investment round from INKEF and existing investors, to advance treatments of neuromuscular disorders | Nordic 9
NMD Pharma, finalist i Life Sciences kategorien - EY Danmark
NMD Pharma on Vimeo
Nete Huus's email & phone | NMD Pharma ApS's Senior Scientist email
NMD Pharma Information | NMD Pharma Profile
Prominent Canadian researcher in Denmark: Why I left a top job in California
Management — NMD Pharma
NMD Pharma picked as Biotech of the Week by Labiotech.eu — NMD Pharma
NMD Pharma Receives Approval to Start a combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
Management — NMD Pharma
NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
NMD Pharma A/S | LinkedIn
NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma | The Org
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis | MENAFN.COM
NMD Pharma - PIR International
Erhverv Aarhus - 照片| Facebook
Labiotech.eu on Twitter: "NMD Pharma, from @AarhusUni, is willing to tackle Neuromuscular Transmission Disorders #BioEquity2016… "
